Search

everythinglearnresearchcommunity

for

Search:↓

New CRISPR/Cas9 variants and nanotechnology-based delivery methods are improving cancer treatment, but choosing the best variant and overcoming certain limitations remain challenges.

Peptide nanoparticles can effectively deliver CRISPR-Cas9 to target KRAS mutations in cancer.

Non-viral delivery systems and stimuli-responsive nanoformulations can improve CRISPR-Cas9 gene therapy.

CRISPR/Cas9 has improved precision and control but still faces clinical challenges.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

Non-viral vectors show promise for safe and effective CRISPR/Cas9 gene editing in treating diseases.

Advancements in nanoformulations for CRISPR-Cas9 genome editing can respond to specific triggers for controlled gene editing, showing promise in treating incurable diseases, but challenges like precision and system design complexity still need to be addressed.

RNA delivery is best for in-body use, while RNP delivery is good for outside-body use. Both methods are expected to greatly impact future treatments.

CRISPR/Cas9 gene-editing shows promise for improving sheep and goat breeding but faces challenges with efficiency and accuracy.

Using CRISPR for gene editing in the body is promising but needs better delivery methods to be more efficient and specific.

A stable, active version of a growth factor was made in bacteria, showing promise for medical use.

CRISPR/Cas9 gene-editing shows promise for livestock breeding but faces challenges like low efficiency and off-target effects.

Caspases affect many cell functions and could help treat various diseases.

The Megsin-Cre transgene is a new tool for genetic manipulation in the skin and upper digestive tract.

KGF-1 135 is a stable and effective alternative for treating oral mucositis.

Nanotechnology improves CRISPR-Cas9 delivery for cancer treatment, but challenges remain.

CRISPR-Cas9 can successfully edit genes in large mammals like Cashmere goats.

Engineered extracellular vesicles could improve CRISPR/Cas delivery, making gene editing safer and more effective.

Ionizable lipid nanoparticles are the best for delivering gene-editing therapies.

Caspases are enzymes important for both cell death and various non-lethal cell functions, affecting head development and hair growth, with different caspases playing specific roles.

CRISPR/Cas systems show promise for cancer treatment by targeting miRNAs, but delivery and specificity challenges remain.

CRISPR/Cas9 and prime editing can potentially fix skin disorder genes safely and effectively.

Researchers used CRISPR/Cas9 to create a goat with a gene that increased cashmere production by 74.5% without affecting quality.

Human and mouse TGase3 enzymes are similar but differ near the activation site, crucial for their function in skin and hair development.

The vector successfully directed specific gene expression in hair follicles.

Transgenic sheep cells with spider silk gene were successfully created for future sheep hair expression.

Newly designed proteins can effectively degrade specific proteins in cells, offering a promising alternative for targeted protein degradation.

Caspases do more than kill cells; they also help in cell growth and disease, and targeting them could lead to new treatments.

Smart delivery methods for CRISPR gene editing are crucial for clinical success.